Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States
Article in Frontiers in Pharmacology (March 2024)
The most recent citing publications are shown below. View all 298 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (March 2024)
Article in Journal of Obstetrics and Gynaecology Research (March 2024)
Article in Journal of Medical Economics (February 2024)